When to Start Antifungal Therapy in the Non-Neutropenic Critically III?

Autor:	D. Pittet, E. Anaissie, J. S. Solomkin
Rok vydání:	1996
Předmět:	Antifungal medicine.medical_specialty medicine.drug_class business.industry Internal medicine Incidence (epidemiology) medicine Infections surveillance business Non neutropenic Oropharyngeal Candidiasis
Zdroj:	Yearbook of Intensive Care and Emergency Medicine ISBN: 9783540605522
DOI:	10.1007/978-3-642-80053-5_46
Popis:	The incidence of fungal infection, particularly with Candida species, has increased dramatically over the past decade [1]. Data from the National Nosocomial Infections Surveillance (NNIS) system show that between 1980 and 1989, the incidence of primary bloodstream infections attributable to Candida species increased by 487% in large teaching hospitals and by 219% in small hospitals ( < 200 beds) [2].
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::59f2c2da9147c9dce30e5a8f88af0061 https://doi.org/10.1007/978-3-642-80053-5_46 Zobrazit plný text záznamu